2026-08-04
What Happened When Stem Cells Were Infused for Acute Ischaemic Stroke — MASTERS and the Answer 'No Difference'
1.2 billion allogeneic MAPC (MultiStem) IV 24–48 h after stroke. MASTERS (double-blind, 137 randomised, 33 UK/US sites) was safe, but the day-90 primary endpoint failed in the 126 analysed (OR 1.08, p=0.83). Plus the 9 years since.
解説を読む →
